Swart S S, Pearson D, Wood J K, Barnett D B
Thromb Res. 1984 Mar 1;33(5):531-41. doi: 10.1016/0049-3848(84)90019-7.
Platelet alpha-adrenoceptor status was examined in 35 patients with myeloproliferative disorders (MPD) and 35 normal controls by means of radioligand binding studies with 3H-yohimbine (3H-YOH) and in vitro platelet function tests. A group of 'adrenaline insensitive' MPD patients identified in the functional studies were found to be identical to normal controls and other MPD patients with respect to their alpha 2-adrenoceptor status as assessed by the binding studies. Possible explanations for the dissociation between radioligand binding studies and functional responses in the platelet are discussed.
通过使用³H-育亨宾(³H-YOH)进行放射性配体结合研究和体外血小板功能测试,对35例骨髓增殖性疾病(MPD)患者和35名正常对照者的血小板α-肾上腺素能受体状态进行了检查。在功能研究中确定的一组“肾上腺素不敏感”MPD患者,就结合研究评估的α2-肾上腺素能受体状态而言,被发现与正常对照者和其他MPD患者相同。讨论了血小板放射性配体结合研究与功能反应之间解离的可能解释。